French Constitutional Council gives the all-clear to biosimilar substitution
This article was originally published in Scrip
Executive Summary
French pharmacists are to have a legal right to substitute a biosimilar medicine for the reference product after the Constitutional Council rejected claims by a group of MPs and Senators that the measure was unconstitutional and should not have been included in the social security financing bill for 2014 that was approved by parliament earlier this month.